News
-
09.02.2010
Debiopharm Group™ grants an exclusive licence for the development, manufacture and commercialisation of Debio 025 - A potent, first-in-class antiviral agent for the treatment of Hepatitis C - -
04.02.2010
Launch of Ipsen’s Decapeptyl® 6-month formulation (LP 22.5 mg) in France for the treatment of locally advanced or metastatic hormone-dependent prostate cancer
Login Form
Home
| Credits |
PhotographsPhotograph of mountains & lake on home page by Jacques Straesslé (copyright Debiopharm). Various scenery and artistic lab photographs by Daniel Choinière (copyright Debiopharm). Scenes from Debio RP by Heinz Preisig (copyright Debiopharm).
The graphic content of the website was designed by François Grieshaber, fgdesign . WebsiteThe technological integration was realised by inetis. |